Novavax, Inc.
Viés de alta
Atualizado

Novavax (NVAX) stock price is on track...for now [LONG]

417
Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one.

This is purely speculation based on their pipeline. This is not financial advice.
Nota
Again, here's the original post:

Novavax (NVAX) - Vaccine Testing - SARS, MERS, SARS-CoV-2 (2019)

Aviso legal

As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.